The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
To 'Post Your News' use the button at the top right.
We are pleased to present below all posts archived in 'November, 2017'. If you still can't find what you are looking for, try using the search box.
HSC-BANKER® from AMSBIO is a new optimised GMP grade cryopreservation medium for the banking of hematopoietic stem cellsisolated from umbilical cord blood, peripheral blood and bone marrow.
Read the rest of entry »
The BioHub Birmingham®, which provides flexible laboratory space for pre-revenue life science companies, has announced its expansion to meet the growing demand for laboratory space in the Midlands.
NASA to evaluate the use of Isansys’ physiological monitoring tools to learn how to monitor explorers as they travel into space. A NASA exploration scientist set off on his mission to Antarctica being monitored by the Patient Status Engine, a physiological data collection platform which provides monitoring of individuals wirelessly and in real-time.
MSD, known as Merck and Co., Inc., in the US and Canada, has today announced its commitment to establish a state of the art life sciences discovery research facility in London, focussed on early bioscience discovery and entrepreneurial innovation
German-headquartered Qiagen are one of the firms expected to expand into a campus in the city
Summit Continues to Expect 24-week Data Q1 2018, which Could Provide Potential Proof of Mechanism for Ezutromid
BioSeed® has been designed to provide a platform for innovative life science companies to present and meet with sector specific early stage investors.
An emerging leader in innovative injectable bio-ceramic bone substitute products to treat bone voids caused by trauma, infection, disease or related surgery based on its unique CERAMENT® platform, announces the publication of a paper highlighting the anti-biofilm activity of CERAMENT®
Former chairman of Sanofi to help drive the commercialization of Pertinax®
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.
This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc. Just drop an email to us, firstname.lastname@example.org, and we will post.